News | December 10, 2008

China Orders 200 B-CAD Systems from Medipattern

December 10, 2008 – The Medipattern Corp. said the China Primary Health Care Foundation (CPHCF) has purchased 200 B-CAD systems as part of a pilot breast-screening program for rural China.

The CPHCF is purchasing equipment for rural hospitals, including B-CAD, as part of their large-scale trial to finalize breast-screening protocol prior to launching their national screening program. Delivery and installation of the first 50 B-CAD software systems will occur during the first quarter of 2009, with subsequent scheduled deliveries in 36 unit increments throughout the first half of 2009. Medipattern will receive a portion of the value of the contract in the form of a down payment, followed by further payments totaling 90 percent of the value of the shipments upon receipt of the software in China. Additional financial and operational details of the transaction were not disclosed due to competitive reasons.

“Breast density has been a limiting factor in being able to perform screening in the People’s Republic of China. Recent studies show that breast ultrasound imaging is more effective on dense breast types than screening mammography and that B-CAD improves diagnostic accuracy of breast ultrasound imaging. It is a necessary part of every breast ultrasound exam and as such we include it with every ultrasound unit that we order for breast diagnosis and screening,” said Tang Jie, M.D., director of ultrasound for the PLA 301 in Beijing. “Breast ultrasound is a central part of our screening program in China.”

Breast cancer is a significant issue in China. The incidence of breast cancer has increased by at least 27 percent over the past decade, and 40 percent of the Chinese women diagnosed with breast cancer die within five years because the cancer is already very advanced when it is diagnosed. According to the October 27, 2008 issue of the Shanghai Daily, Shanghai has the highest incidence of breast cancer in China. More than 60 in every 100,000 women in the city contract the disease, which is three times higher than the incidence in the U.S. and Canada.

Related Content

Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing AI prod
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...